At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 66 enrolled
Drug / intervention
Intralipid, 20% Intravenous Emulsion +1 moredrug
Likely dose
Intralipid, 20% Intravenous Emulsion 1 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
The University of Texas Health Science Center, Houston·interventional·Posted Feb 28, 2019·Updated Mar 3, 2025
In Brief
A Phase 4 clinical trial evaluating Intralipid, 20% Intravenous Emulsion and Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipid for Prematurity. Completed, enrolled 66 participants across 1 site.
Detailed Summary
The goal of this research study is to compare the levels of free fatty acids and free bilirubin between two intravenous lipid emulsion products in premature newborns.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrematurity
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedFeb 2019
Enrollment StartMar 2019
Primary CompletionJun 2020
TodayJul 2026
First PostedFeb 28, 2019
Enrollment StartMar 2, 2019
Primary CompletionJun 11, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.3 years ago
Interventions
Intralipid, 20% Intravenous Emulsiondrug
Lipids start at 1 g/kg/day and advance by 1 g/kg/day to a maximum of 3 g/kg/day as tolerated by the the neonate.
Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipiddrug
Lipids start at 1 g/kg/day and advance by 1 g/kg/day to a maximum of 3 g/kg/day as tolerated by the the neonate.